Cargando…
Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options
Macular dystrophies (MDs) consist of a heterogeneous group of disorders that are characterised by bilateral symmetrical central visual loss. Advances in genetic testing over the last decade have led to improved knowledge of the underlying molecular basis. The developments in high-resolution multimod...
Autores principales: | Rahman, Najiha, Georgiou, Michalis, Khan, Kamron N, Michaelides, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147237/ https://www.ncbi.nlm.nih.gov/pubmed/31704701 http://dx.doi.org/10.1136/bjophthalmol-2019-315086 |
Ejemplares similares
-
Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy
por: Gill, Jasdeep S, et al.
Publicado: (2019) -
IMPG2-associated unilateral adult onset vitelliform macular dystrophy
por: Georgiou, Michalis, et al.
Publicado: (2022) -
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
por: Tanna, Preena, et al.
Publicado: (2017) -
Autosomal Recessive Bestrophinopathy: Clinical Features, Natural History, and Genetic Findings in Preparation for Clinical Trials
por: Casalino, Giuseppe, et al.
Publicado: (2021) -
KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy
por: Guimaraes, Thales A. C. De, et al.
Publicado: (2020)